Dáil Éireann Debate, Thursday - 24 September 2020
288. Deputy Denis Naughten asked the Minister for Agriculture, Food and the Marine the way in which he plans to ensure that the new antiparasitic medicine regime to be implemented from January 2022 retains a substantive role for existing stakeholders and delivers value for money for farmers here; and if he will make a statement on the matter. [26164/20]
View answer300. Deputy Brendan Smith asked the Minister for Agriculture, Food and the Marine if he will ensure that suitably qualified persons, licensed merchant stores and veterinary pharmacies will be able to continue the prescribing and supply of anthelmintics; and if he will make a statement on the matter. [26213/20]
View answerI propose to take Questions Nos. 288 and 300 together.
EU Regulation 2019/6 on veterinary medicinal products comes into effect in January 2022. This Regulation is binding in full and has direct effect on all Member States.
Two issues have now arisen
1. The new requirement under EU Law for a veterinary prescription to be issued before antiparasitic products can be dispensed and
2. The question as to whether Ireland can avail of a derogation in the Regulation which permits professionals other than veterinarians to issue veterinary prescriptions.
In relation to the first issue, since 2004 European legislation established a requirement that all veterinary medicinal products that are intended for use in food-producing animals should be subject to a veterinary prescription. However, a 2006 EU Directive allowed for the maintenance of non-prescription status for certain veterinary medicinal products which did not present a risk to human or animal health or to the environment. Ireland availed of the exemption in Directive 2006/130/EC at the time and antiparasitics were allowed to continue to be available without prescription.
There is a similar exemption available under the new EU Regulation 2019/6. However, since that time, our knowledge regarding the impact of extensive use of antiparasitics has changed. In 2019, the Health Product Regulatory Authority’s (HPRA) Advisory Committee for Veterinary Medicines (ACVM) established a Task Force to review the method of supply of antiparasitic veterinary medicinal products that are intended for food-producing animals against the criteria set out in Regulation 2019/6. A copy of the Report is available on the HPRA’s website www.hpra.ie.
The Report states that the available scientific evidence shows that antiparasitic veterinary medicines that are intended for use in food-producing species do not comply with the criteria for derogation from veterinary prescription specified in EU Regulation 2019/6. Therefore antiparasitic veterinary medicines must require a veterinary prescription before they can be dispensed from January 2022. Ireland has no national discretion on this issue.
On the second issue, there is a separate derogation in the Regulation, which allows professionals other than veterinarians to issue veterinary prescriptions, in limited circumstances, but only if this was provided for in a Member State's national legislation prior to Regulation 2019/6 coming into force in January 2019.
Ireland's national legislation has never permitted anyone other than a veterinarian to issue a veterinary prescription. Therefore, Ireland has no national discretion to now provide for a regime which would permit Responsible Persons in Licensed Merchants or pharmacists to dispense antiparasitic veterinary medicines without a veterinary prescription issued by a veterinarian.
I recognise these legislative changes will result in challenges for all impacted stakeholders. In recognition of this, my Department has established an Antiparasitic Resistance Stakeholder Group chaired by the Chief Veterinary Officer. Two meetings have been held to date and a programme of work containing over 30 antiparasitic related projects is currently underway. This group will examine all the issues related to the changed route of supply with two principal objectives
- Protecting the efficacy of antiparasitics which are critical to the Irish pasture-based production model.
- Establishing a regulatory system that is pragmatic, retains a substantive role for existing stakeholders and delivers value for money for farmers
My Department is fully committed to working with all stakeholders in considering how best to implement the new EU Regulations on veterinary medicinal products. There is a dedicated email address allowing communications on the new Regulation: vetmedregs@agricuIture.gov.ie.
